Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation

Journal of Experimental Medicine

Volumn 209, Issue 7, 2012, Pages 1335-1348

  Joo, HyeMee ^a   Coquery, Christine ^a   Xue, Yaming ^a   Gayet, Ingrid ^a   Dillon, Stacey R ^b   Punaro, Marilynn ^c   Zurawski, Gerard ^a   Banchereau, Jacques ^d   Pascual, Virginia ^a   Oh, SangKon ^a  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b ZYMOGENETICS INC   (United States)

^c TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^d Pharma Research and Early Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 10; SYNDECAN 1;

ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CHILD; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MEMORY CELL; MONOCYTE; MYELOID DENDRITIC CELL; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

EID: 84864296905     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20111644     Document Type: Article

References (66)

1. Arbuckle, M.R., M.T. McClain, M.V. Rubertone, R.H. Scofield, G.J. Dennis, J.A. James, and J.B. Harley. 2003. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349:1526-1533. http://dx.doi.org/10.1056/NEJMoa021933
2. Arce, E., D.G. Jackson, M.A. Gill, L.B. Bennett, J. Banchereau, and V. Pascual. 2001. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J. Immunol. 167:2361-2369.
3. Arpin, C., J. Déchanet, C. Van Kooten, P. Merville, G. Grouard, F. Brière, J. Banchereau, and Y.J. Liu. 1995. Generation of memory B cells and plasma cells in vitro. Science. 268:720-722. http://dx.doi.org/10.1126/science.7537388
4. Banchereau, J., V. Pascual, and A.K. Palucka. 2004. Autoimmunity through cytokine-induced dendritic cell activation. Immunity. 20:539-550. http://dx.doi.org/10.1016/S1074-7613(04)00108-6
5. Bernasconi, N.L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 298:2199-2202. http://dx.doi.org/10.1126/science.1076071
6. Blanco, P., A.K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science. 294:1540-1543. http://dx.doi.org/10.1126/science.1064890
7. Burdin, N., C. Van Kooten, L. Galibert, J.S. Abrams, J. Wijdenes, J. Banchereau, and F. Rousset. 1995. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J. Immunol. 154:2533-2544.
8. Cappione, A. III, J.H. Anolik, A. Pugh-Bernard, J. Barnard, P. Dutcher, G. Silverman, and I. Sanz. 2005. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J. Clin. Invest. 115:3205-3216. http://dx.doi.org/10.1172/JCI24179
9. Cheema, G.S., V. Roschke, D.M. Hilbert, and W. Stohl. 2001. Elevated serum B lymphocyte stimulator levels in patients with systemic immunebased rheumatic diseases. Arthritis Rheum. 44:1313-1319. http://dx.doi .org/10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S
10. Conley, M.E., and W.J. Koopman. 1983. Serum IgA1 and IgA2 in normal adults and patients with systemic lupus erythematosus and hepatic disease. Clin. Immunol. Immunopathol. 26:390-397. http://dx.doi.org/10.1016/0090-1229(83)90123-X
11. Crispín, J.C., V.C. Kyttaris, C. Terhorst, and G.C. Tsokos. 2010. T cells as therapeutic targets in SLE. Nat. Rev. Rheumatol. 6:317-325. http://dx.doi.org/10.1038/nrrheum.2010.60
12. Dillon, S.R., J.A. Gross, S.M. Ansell, and A.J. Novak. 2006. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat. Rev. Drug Discov. 5:235-246. http://dx.doi.org/10.1038/nrd1982
13. Donadio, J.V. Jr., D.L. Conn, K.E. Holley, and D.M. Ilstrup. 1978. Class of immunoglobulin deposition and prognosis in lupus nephritis. Mayo Clin. Proc. 53:366-372.
14. Dubois, B., B. Vanbervliet, J. Fayette, C. Massacrier, C. Van Kooten, F. Brière, J. Banchereau, and C. Caux. 1997. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185:941-951. http://dx.doi.org/10.1084/jem.185.5.941
15. Dullaers, M., D. Li, Y. Xue, L. Ni, I. Gayet, R. Morita, H. Ueno, K.A. Palucka, J. Banchereau, and S. Oh. 2009. A T cell-dependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts. Immunity. 30:120-129. http://dx.doi.org/10 .1016/j.immuni.2008.11.008
16. Fagarasan, S., and T. Honjo. 2000. T-Independent immune response: new aspects of B cell biology. Science. 290:89-92. http://dx.doi.org/10.1126/science.290.5489.89
17. Florquin, S., A. Roos, J.W. Groothoff, N. Claessen, D.J. van Gijlswijk-Janssen, J. Aten, J.C. Davin, and J.J. Weening. 2001. Severe non-proliferative lupus nephritis with predominant sub-endothelial IgA deposits. Nephrol. Dial. Transplant. 16:1479-1482. http://dx.doi.org/10.1093/ndt/16.7.1479
18. Furuichi, K., T. Wada, N. Sakai, Y. Iwata, K. Yoshimoto, M. Shimizu, K. Kobayashi, K. Takasawa, H. Kida, S.I. Takeda, et al. 2000. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases. Am. J. Nephrol. 20:291-299. http://dx.doi.org/10.1159/000013603
19. Gill, M.A., P. Blanco, E. Arce, V. Pascual, J. Banchereau, and A.K. Palucka. 2002. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum. Immunol. 63:1172-1180. http://dx.doi.org/10.1016/S0198-8859(02)00756-5
20. Grimaldi, C.M., D.J. Michael, and B. Diamond. 2001. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 167:1886-1890.
21. Grimaldi, C.M., J. Cleary, A.S. Dagtas, D. Moussai, and B. Diamond. 2002. Estrogen alters thresholds for B cell apoptosis and activation. J. Clin. Invest. 109:1625-1633.
22. Gross, J.A., J. Johnston, S. Mudri, R. Enselman, S.R. Dillon, K. Madden, W. Xu, J. Parrish-Novak, D. Foster, C. Lofton-Day, et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 404:995-999. http://dx.doi.org/10.1038/35010115
23. He, B., X. Qiao, and A. Cerutti. 2004. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J. Immunol. 173:4479-4491.
24. He, B., W. Xu, P.A. Santini, A.D. Polydorides, A. Chiu, J. Estrella, M. Shan, A. Chadburn, V. Villanacci, A. Plebani, et al. 2007. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity. 26:812-826. http://dx.doi.org/10.1016/j.immuni.2007.04.014
25. Hendriks, J., L. Planelles, J. de Jong-Odding, G. Hardenberg, S.T. Pals, M. Hahne, M. Spaargaren, and J.P. Medema. 2005. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ. 12:637-648. http://dx.doi.org/10.1038/sj.cdd.4401647
26. Huard, B., T. McKee, C. Bosshard, S. Durual, T. Matthes, S. Myit, O. Donze, C. Frossard, C. Chizzolini, C. Favre, et al. 2008. APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. J. Clin. Invest. 118:2887-2895.
27. - naive human B cells. Blood. 109:1611-1619. http://dx.doi.org/10.1182/blood-2006-03-008441
28. Ingold, K., A. Zumsteg, A. Tardivel, B. Huard, Q.G. Steiner, T.G. Cachero, F. Qiang, L. Gorelik, S.L. Kalled, H. Acha-Orbea, et al. 2005. Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 201:1375-1383. http://dx.doi.org/10.1084/jem.20042309
29. Jego, G., A.K. Palucka, J.P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau. 2003. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity. 19:225-234. http://dx .doi.org/10.1016/S1074-7613(03)00208-5
30. Jiang, W., M.M. Lederman, C.V. Harding, B. Rodriguez, R.J. Mohner, and S.F. Sieg. 2007. TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function. Eur. J. Immunol. 37:2205-2213. http://dx.doi.org/10.1002/eji.200636984
31. Kang, K.Y., H.O. Kim, S.K. Kwok, J.H. Ju, K.S. Park, D.I. Sun, J.Y. Jhun, H.J. Oh, S.H. Park, and H.Y. Kim. 2011. Impact of interleukin-21 in the pathogenesis of primary Sjogren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands. Arthritis Res. Ther. 13:R179. http://dx.doi.org/10.1186/ar3504
32. Koffler, D., V. Agnello, R. Thoburn, and H.G. Kunkel. 1971. Systemic lupus erythematosus: Prototype of immune complex nephritis in man. J. Exp. Med. 134:169-179. http://dx.doi.org/10.1084/jem.134.3.169
33. Kotzin, B.L. 1996. Systemic lupus erythematosus. Cell. 85:303-306. http://dx.doi.org/10.1016/S0092-8674(00)81108-3
34. Koyama, T., H. Tsukamoto, Y. Miyagi, D. Himeji, J. Otsuka, H. Miyagawa, M. Harada, and T. Horiuchi. 2005. Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 64:1065-1067. http://dx.doi.org/10.1136/ard.2004.022491
35. Krieg, A.M., A.K. Yi, S. Matson, T.J. Waldschmidt, G.A. Bishop, R. Teasdale, G.A. Koretzky, and D.M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:546-549. http://dx.doi.org/10.1038/374546a0
36. Kumar, S., E. Papalardo, P. Sunkureddi, S. Najam, E.B. González, and S.S. Pierangeli. 2009. Isolated elevation of IgA anti-beta2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients. Lupus. 18:1011-1014. http://dx.doi.org/10.1177/0961203309103048
37. Kuo, P., M.S. Bynoe, C. Wang, and B. Diamond. 1999. Bcl-2 leads to expression of anti-DNA B cells but no nephritis: a model for a clinical subset. Eur. J. Immunol. 29:3168-3178. http://dx.doi.org/10.1002/(SICI)1521-4141(199910)29:10<3168::AID-IMMU3168>3.0.CO;2-H
38. Lin, G.G., and J.M. Li. 2009. IgG subclass serum levels in systemic lupus erythematosus patients. Clin. Rheumatol. 28:1315-1318. http://dx.doi .org/10.1007/s10067-009-1224-x
39. Lit, L.C., C.K. Wong, L.S. Tam, E.K. Li, and C.W. Lam. 2006. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 65:209-215. http://dx.doi.org/10.1136/ard.2005.038315
40. Litinskiy, M.B., B. Nardelli, D.M. Hilbert, B. He, A. Schaffer, P. Casali, and A. Cerutti. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3:822-829. http://dx.doi.org/10.1038/ni829
41. Liu, K., Q.Z. Li, Y. Yu, C. Liang, S. Subramanian, Z. Zeng, H.W. Wang, C. Xie, X.J. Zhou, C. Mohan, and E.K. Wakeland. 2007. Sle3 and Sle5 can independently couple with Sle1 to mediate severe lupus nephritis. Genes Immun. 8:634-645. http://dx.doi.org/10.1038/sj.gene.6364426
42. Mackay, F., S.A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J.L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190:1697-1710. http://dx.doi.org/10.1084/jem.190.11.1697
43. Matei, L., and I. Matei. 2000-2001. Lectin-binding profile of serum IgA in women suffering from systemic autoimmune rheumatic disorders. Rom. J. Intern. Med. 38-39:73-82.
44. Mehrani, T., and M. Petri. 2011a. Association of IgA Anti-beta2 glycoprotein I with clinical and laboratory manifestations of systemic lupus erythematosus. J. Rheumatol. 38:64-68. http://dx.doi.org/10.3899/jrheum .100568
45. Mehrani, T., and M. Petri. 2011b. IgM anti-beta2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus. J. Rheumatol. 38:450-453. http://dx.doi.org/10.3899/jrheum.100650
46. Mietzner, B., M. Tsuiji, J. Scheid, K. Velinzon, T. Tiller, K. Abraham, J.B. Gonzalez, V. Pascual, D. Stichweh, H. Wardemann, and M.C. Nussenzweig. 2008. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc. Natl. Acad. Sci. USA. 105:9727-9732. http://dx.doi .org/10.1073/pnas.0803644105
47. Moreaux, J., A.C. Sprynski, S.R. Dillon, K. Mahtouk, M. Jourdan, A. Ythier, P. Moine, N. Robert, E. Jourdan, J.F. Rossi, and B. Klein. 2009. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop. Eur. J. Haematol. 83:119-129. http://dx.doi.org/10.1111/j.1600-0609.2009.01262.x
48. Odendahl, M., A. Jacobi, A. Hansen, E. Feist, F. Hiepe, G.R. Burmester, P.E. Lipsky, A. Radbruch, and T. Dörner. 2000. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J. Immunol. 165:5970-5979.
49. Ohnmacht, C., A. Pullner, S.B. King, I. Drexler, S. Meier, T. Brocker, and D. Voehringer. 2009. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 206:549-559. http://dx.doi.org/10.1084/jem.20082394
50. Pascual, V., J. Banchereau, and A.K. Palucka. 2003. The central role of dendritic cells and interferon-alpha in SLE. Curr. Opin. Rheumatol. 15:548-556. http://dx.doi.org/10.1097/00002281-200309000-00005
51. Pugh-Bernard, A.E., G.J. Silverman, A.J. Cappione, M.E. Villano, D.H. Ryan, R.A. Insel, and I. Sanz. 2001. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J. Clin. Invest. 108:1061-1070.
52. Santulli-Marotto, S., Y. Qian, S. Ferguson, and S.H. Clarke. 2001. Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response. J. Immunol. 166: 5292-5299.
53. Sanz, I., and F.E. Lee. 2010. B cells as therapeutic targets in SLE. Nat. Rev. Rheumatol. 6:326-337. http://dx.doi.org/10.1038/nrrheum.2010.68 Schneider, P. 2005. The role of APRIL and BAFF in lymphocyte activation. Curr. Opin. Immunol. 17:282-289. http://dx.doi.org/10.1016/j.coi.2005 .04.005
54. Stasikowska, O., M. Danilewicz, and M. Wagrowska-Danilewicz. 2007. The significant role of RANTES and CCR5 in progressive tubulointerstitial lesions in lupus nephropathy. Pol. J. Pathol. 58:35-40.
55. Stohl, W., S. Metyas, S.M. Tan, G.S. Cheema, B. Oamar, D. Xu, V. Roschke, Y. Wu, K.P. Baker, and D.M. Hilbert. 2003. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum. 48:3475-3486. http://dx.doi.org/10.1002/art.11354
56. Sweiss, N.J., R. Bo, R. Kapadia, D. Manst, F. Mahmood, T. Adhikari, S. Volkov, M. Badaracco, M. Smaron, A. Chang, et al. 2010. IgA antibeta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus. PLoS ONE. 5:e12280. http://dx.doi.org/10.1371/journal .pone.0012280
57. Teichmann, L.L., M.L. Ols, M. Kashgarian, B. Reizis, D.H. Kaplan, and M.J. Shlomchik. 2010. Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. Immunity. 33:967-978. http://dx.doi.org/10.1016/j.immuni.2010 .11.025
58. Van Gorp, H., P.L. Delputte, and H.J. Nauwynck. 2010. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Mol. Immunol. 47:1650-1660. http://dx.doi.org/10.1016/j.molimm.2010.02.008
59. Vilá, L.M., M.J. Molina, A.M. Mayor, J.J. Cruz, E. Ríos-Olivares, and Z. Ríos. 2007. Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus. Clin. Rheumatol. 26:718-722. http://dx.doi .org/10.1007/s10067-006-0387-y
60. Wardemann, H., S. Yurasov, A. Schaefer, J.W. Young, E. Meffre, and M.C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science. 301:1374-1377. http://dx.doi.org/10.1126/science.1086907
61. Wei, C., J. Anolik, A. Cappione, B. Zheng, A. Pugh-Bernard, J. Brooks, E.H. Lee, E.C. Milner, and I. Sanz. 2007. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J. Immunol. 178:6624-6633.
62. Wilson, W.A., Z. Faghiri, F. Taheri, and A.E. Gharavi. 1998. Significance of IgA antiphospholipid antibodies. Lupus. 7:S110-S113. http://dx.doi .org/10.1177/096120339800700225
63. Xu, W., B. He, A. Chiu, A. Chadburn, M. Shan, M. Buldys, A. Ding, D.M. Knowles, P.A. Santini, and A. Cerutti. 2007. Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat. Immunol. 8:294-303. http://dx.doi.org/10.1038/ni1434
64. Yoshizaki, K., T. Nakagawa, T. Kaieda, A. Muraguchi, Y. Yamamura, and T. Kishimoto. 1982. Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors. J. Immunol. 128:1296-1301.
65. Yurasov, S., H. Wardemann, J. Hammersen, M. Tsuiji, E. Meffre, V. Pascual, and M.C. Nussenzweig. 2005. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201:703-711. http://dx.doi.org/10.1084/jem.20042251
66. Yurasov, S., T. Tiller, M. Tsuiji, K. Velinzon, V. Pascual, H. Wardemann, and M.C. Nussenzweig. 2006. Persistent expression of autoantibodies in SLE patients in remission. J. Exp. Med. 203:2255-2261. http://dx.doi .org/10.1084/jem.20061446